These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 37550964)

  • 1. Robust cross-cohort gut microbiome associations with COVID-19 severity.
    Li J; Ghosh TS; McCann R; Mallon P; Hill C; Draper L; Schult D; Fanning LJ; Shannon R; Sadlier C; Horgan M; O'Mahony L; O'Toole PW
    Gut Microbes; 2023; 15(1):2242615. PubMed ID: 37550964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The gut microbiome of COVID-19 recovered patients returns to uninfected status in a minority-dominated United States cohort.
    Newsome RC; Gauthier J; Hernandez MC; Abraham GE; Robinson TO; Williams HB; Sloan M; Owings A; Laird H; Christian T; Pride Y; Wilson KJ; Hasan M; Parker A; Senitko M; Glover SC; Gharaibeh RZ; Jobin C
    Gut Microbes; 2021; 13(1):1-15. PubMed ID: 34100340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of gut microbiota with the pathogenesis of SARS-CoV-2 Infection in people living with HIV.
    Ishizaka A; Koga M; Mizutani T; Yamayoshi S; Iwatsuki-Horimoto K; Adachi E; Suzuki Y; Kawaoka Y; Yotsuyanagi H
    BMC Microbiol; 2024 Jan; 24(1):6. PubMed ID: 38172680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Pro-Inflammatory Gut Microbiome Characterizes SARS-CoV-2 Infected Patients and a Reduction in the Connectivity of an Anti-Inflammatory Bacterial Network Associates With Severe COVID-19.
    Reinold J; Farahpour F; Fehring C; Dolff S; Konik M; Korth J; van Baal L; Hoffmann D; Buer J; Witzke O; Westendorf AM; Kehrmann J
    Front Cell Infect Microbiol; 2021; 11():747816. PubMed ID: 34869058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization.
    Zuo T; Zhang F; Lui GCY; Yeoh YK; Li AYL; Zhan H; Wan Y; Chung ACK; Cheung CP; Chen N; Lai CKC; Chen Z; Tso EYK; Fung KSC; Chan V; Ling L; Joynt G; Hui DSC; Chan FKL; Chan PKS; Ng SC
    Gastroenterology; 2020 Sep; 159(3):944-955.e8. PubMed ID: 32442562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19 alters human microbiomes: a meta-analysis.
    Reuben RC; Beugnon R; Jurburg SD
    Front Cell Infect Microbiol; 2023; 13():1211348. PubMed ID: 37600938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonged Impairment of Short-Chain Fatty Acid and L-Isoleucine Biosynthesis in Gut Microbiome in Patients With COVID-19.
    Zhang F; Wan Y; Zuo T; Yeoh YK; Liu Q; Zhang L; Zhan H; Lu W; Xu W; Lui GCY; Li AYL; Cheung CP; Wong CK; Chan PKS; Chan FKL; Ng SC
    Gastroenterology; 2022 Feb; 162(2):548-561.e4. PubMed ID: 34687739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Signatures of disease outcome severity in the intestinal fungal and bacterial microbiome of COVID-19 patients.
    Rizzello F; Viciani E; Gionchetti P; Filippone E; Imbesi V; Melotti L; Dussias NK; Salice M; Santacroce B; Padella A; Velichevskaya A; Marcante A; Castagnetti A
    Front Cell Infect Microbiol; 2024; 14():1352202. PubMed ID: 38510960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations of the Gut Microbiota in Patients With Coronavirus Disease 2019 or H1N1 Influenza.
    Gu S; Chen Y; Wu Z; Chen Y; Gao H; Lv L; Guo F; Zhang X; Luo R; Huang C; Lu H; Zheng B; Zhang J; Yan R; Zhang H; Jiang H; Xu Q; Guo J; Gong Y; Tang L; Li L
    Clin Infect Dis; 2020 Dec; 71(10):2669-2678. PubMed ID: 32497191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Relationship Between Pediatric Gut Microbiota and SARS-CoV-2 Infection.
    Romani L; Del Chierico F; Macari G; Pane S; Ristori MV; Guarrasi V; Gardini S; Pascucci GR; Cotugno N; Perno CF; Rossi P; Villani A; Bernardi S; Campana A; Palma P; Putignani L;
    Front Cell Infect Microbiol; 2022; 12():908492. PubMed ID: 35873161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut bacterial dysbiosis and instability is associated with the onset of complications and mortality in COVID-19.
    Schult D; Reitmeier S; Koyumdzhieva P; Lahmer T; Middelhoff M; Erber J; Schneider J; Kager J; Frolova M; Horstmann J; Fricke L; Steiger K; Jesinghaus M; Janssen KP; Protzer U; Neuhaus K; Schmid RM; Haller D; Quante M
    Gut Microbes; 2022; 14(1):2031840. PubMed ID: 35174781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19.
    Yeoh YK; Zuo T; Lui GC; Zhang F; Liu Q; Li AY; Chung AC; Cheung CP; Tso EY; Fung KS; Chan V; Ling L; Joynt G; Hui DS; Chow KM; Ng SSS; Li TC; Ng RW; Yip TC; Wong GL; Chan FK; Wong CK; Chan PK; Ng SC
    Gut; 2021 Apr; 70(4):698-706. PubMed ID: 33431578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alteration of the gut microbiota's composition and metabolic output correlates with COVID-19-like severity in obese NASH hamsters.
    Sencio V; Benech N; Robil C; Deruyter L; Heumel S; Machelart A; Sulpice T; Lamazière A; Grangette C; Briand F; Sokol H; Trottein F
    Gut Microbes; 2022; 14(1):2100200. PubMed ID: 35830432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2 infection and viral load are associated with the upper respiratory tract microbiome.
    Rosas-Salazar C; Kimura KS; Shilts MH; Strickland BA; Freeman MH; Wessinger BC; Gupta V; Brown HM; Rajagopala SV; Turner JH; Das SR
    J Allergy Clin Immunol; 2021 Apr; 147(4):1226-1233.e2. PubMed ID: 33577896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Temporal landscape of human gut RNA and DNA virome in SARS-CoV-2 infection and severity.
    Zuo T; Liu Q; Zhang F; Yeoh YK; Wan Y; Zhan H; Lui GCY; Chen Z; Li AYL; Cheung CP; Chen N; Lv W; Ng RWY; Tso EYK; Fung KSC; Chan V; Ling L; Joynt G; Hui DSC; Chan FKL; Chan PKS; Ng SC
    Microbiome; 2021 Apr; 9(1):91. PubMed ID: 33853691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of microbiota in the gut and upper respiratory tract associated with SARS-CoV-2 infection.
    Li J; Jing Q; Li J; Hua M; Di L; Song C; Huang Y; Wang J; Chen C; Wu AR
    Microbiome; 2023 Mar; 11(1):38. PubMed ID: 36869345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diversity, composition, and networking of saliva microbiota distinguish the severity of COVID-19 episodes as revealed by an analysis of 16S rRNA variable V1-V3 region sequences.
    Larios Serrato V; Meza B; Gonzalez-Torres C; Gaytan-Cervantes J; González Ibarra J; Santacruz Tinoco CE; Anguiano Hernández YM; Martínez Miguel B; Cázarez Cortazar A; Sarquiz Martínez B; Alvarado Yaah JE; Mendoza Pérez AR; Palma Herrera JJ; García Soto LM; Chávez Rojas AI; Bravo Mateos G; Samano Marquez G; Grajales Muñiz C; Torres J
    mSystems; 2023 Aug; 8(4):e0106222. PubMed ID: 37310423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma Microbiome in COVID-19 Subjects: An Indicator of Gut Barrier Defects and Dysbiosis.
    Prasad R; Patton MJ; Floyd JL; Fortmann S; DuPont M; Harbour A; Wright J; Lamendella R; Stevens BR; Oudit GY; Grant MB
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Fungal Gut Microbiome Exhibits Reduced Diversity and Increased Relative Abundance of Ascomycota in Severe COVID-19 Illness and Distinct Interconnected Communities in SARS-CoV-2 Positive Patients.
    Reinold J; Farahpour F; Schoerding AK; Fehring C; Dolff S; Konik M; Korth J; van Baal L; Buer J; Witzke O; Westendorf AM; Kehrmann J
    Front Cell Infect Microbiol; 2022; 12():848650. PubMed ID: 35521219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.